SI-BONE, Inc. (SIBN)
18.08
-0.33
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
18.08
0.00 (0.00%)
After-Hours: 20:00
SI-BONE EPS Diluted (Quarterly) : -0.0919 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0919 |
| March 31, 2026 | -0.0986 |
| December 31, 2025 | -0.0379 |
| September 30, 2025 | -0.1057 |
| June 30, 2025 | -0.1438 |
| March 31, 2025 | -0.1545 |
| December 31, 2024 | -0.1071 |
| September 30, 2024 | -0.1576 |
| June 30, 2024 | -0.2164 |
| March 31, 2024 | -0.2664 |
| December 31, 2023 | -0.2706 |
| September 30, 2023 | -0.2489 |
| June 30, 2023 | -0.296 |
| March 31, 2023 | -0.3186 |
| December 31, 2022 | -0.323 |
| September 30, 2022 | -0.4121 |
| June 30, 2022 | -0.5437 |
| March 31, 2022 | -0.5152 |
| December 31, 2021 | -0.4313 |
| September 30, 2021 | -0.4761 |
| June 30, 2021 | -0.4239 |
| March 31, 2021 | -0.3745 |
| Date | Value |
|---|---|
| December 31, 2020 | -0.2828 |
| September 30, 2020 | -0.33 |
| June 30, 2020 | -0.4408 |
| March 31, 2020 | -0.4687 |
| December 31, 2019 | -0.3635 |
| September 30, 2019 | -0.4558 |
| June 30, 2019 | -0.3521 |
| March 31, 2019 | -0.3831 |
| December 31, 2018 | -0.2579 |
| September 30, 2018 | -0.1969 |
| December 31, 2017 | -0.2037 |
| September 30, 2017 | -0.2335 |
| June 30, 2017 | -0.2435 |
| March 31, 2017 | -0.2737 |
| March 31, 2016 | -0.2758 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.1563 |
| December 31, 2014 | -0.3565 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.1563 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.088M |
| Revenue (Quarterly) | 56.01M |
| Total Expenses (Quarterly) | 60.10M |
| Enterprise Value | 704.98M |
| Gross Profit Margin (Quarterly) | 79.54% |
| Profit Margin (Quarterly) | -7.30% |
| Earnings Yield | -1.85% |
| Normalized Earnings Yield | -1.848 |